U.S. Leisure Stock News

NasdaqCM:TC
NasdaqCM:TCMedia

Token Cat (NasdaqCM:TC) Sharp H1 Loss Narrowing Tests Bearish High P/S Narrative

Token Cat (TC) has just posted its H1 2025 numbers, with revenue of C¥19.8 million and a net income loss of C¥0.7 million, translating to basic EPS of C¥5.74 loss per share, while trailing 12 month figures show revenue of C¥36.6 million and a net loss of C¥148.0 million, or C¥1,200.49 loss per share. Over recent half year periods the company has seen revenue move from C¥32.3 million in H1 2024 to C¥16.9 million in H2 2024 and then to C¥19.8 million in H1 2025. Over the same periods, EPS...
NasdaqGS:AFYA
NasdaqGS:AFYAConsumer Services

Afya’s Solid Earnings Meet Valuation Discount And AI Headwinds

Afya (NasdaqGS:AFYA) reports revenue and EBITDA growth, highlighting resilient financial performance in its latest earnings update. The Medical Practice Solutions segment faces pressure from declining active payers and stronger competition from AI driven tools. These developments point to a mixed picture for Afya, with solid headline results and emerging challenges beneath the surface. Afya operates across medical education and healthcare services in Brazil, and its latest report underlines...
NasdaqGS:WYNN
NasdaqGS:WYNNHospitality

A Look At Wynn Resorts (WYNN) Valuation After Strong Q1 2026 Results And Macau Expansion Plans

Earnings jump and Macau expansion plan put Wynn Resorts (WYNN) in focus Wynn Resorts (WYNN) is back on investors' radar after reporting higher first quarter 2026 revenue and net income than a year earlier, alongside a new expansion project at Wynn Palace in Macau. The company posted first quarter sales of US$1,467.61 million and total revenue of US$1,856.76 million, compared with US$1,314.95 million and US$1,700.40 million respectively in the prior year period. Net income came in at US$120.45...
NasdaqGS:SANM
NasdaqGS:SANMElectronic

Why Sanmina (SANM) Is Up 8.8% After Strong Q2 Results And New $600 Million Buyback Program

In late April 2026, Sanmina Corporation reported second-quarter fiscal 2026 results showing sales of US$4,013.27 million and net income of US$93.65 million, while outlining new revenue guidance for the third quarter and full year and expanding its capital return plans with a fresh US$600 million share repurchase authorization. Alongside this, Sanmina signaled an appetite for acquisitions that meet its return thresholds, filed a US$230.59 million employee stock offering shelf, and saw its...
NYSE:GPK
NYSE:GPKPackaging

A Look At Graphic Packaging Holding’s Valuation After Its Q1 2026 Earnings Beat And Reaffirmed Guidance

Graphic Packaging Holding (GPK) just delivered first quarter 2026 results that topped analyst expectations for both revenue and adjusted earnings per share, even as higher costs and restructuring pushed the company into a net loss. See our latest analysis for Graphic Packaging Holding. The stock is up 15.9% over the past month on a share price basis, helped by the Q1 earnings beat and reaffirmed guidance. However, the 1 year total shareholder return of 49.2% and 3 year total shareholder...
NasdaqGM:WLDN
NasdaqGM:WLDNProfessional Services

Is Strong Q1 Results And Burton Deal Altering The Investment Case For Willdan Group (WLDN)?

Willdan Group, Inc. reported first-quarter 2026 results with sales of US$155.11 million, net income of US$8.53 million, and diluted EPS of US$0.55, all higher than the prior year period. The company also completed its Burton Energy Group acquisition and raised full-year 2026 adjusted EBITDA growth guidance, highlighting expanding commercial energy services and a broader Fortune 500 client base. We’ll now examine how the raised 2026 adjusted EBITDA guidance following the Burton Energy Group...
NasdaqGS:SFM
NasdaqGS:SFMConsumer Retailing

Is Sprouts Farmers Market (SFM) Still Attractive After Recent Share Price Volatility?

For readers considering whether Sprouts Farmers Market at around US$80.99 still represents good value, or whether the key part of the move has already occurred, this article outlines what the current price may be implying. The stock has been choppy recently, with a 1% slip over the last week, a 5% gain over the last month, a modest 0.4% return year to date, and a 48.8% decline over the past year. This sits alongside a 120.3% return over three years and 212.8% over five years. These moves...
NYSE:BWA
NYSE:BWAAuto Components

Is It Too Late To Consider BorgWarner (BWA) After Its Strong 1 Year Share Price Run

Wondering if BorgWarner stock still offers value after a strong run, or if you might be turning up late to the story? The stock last closed at US$58.18, with returns of 2.1% over 7 days, 11.1% over 30 days, 24.7% year to date, 89.5% over 1 year, 54.3% over 3 years and 40.1% over 5 years. Recent coverage has focused on BorgWarner's position in auto components and how investors are treating the stock in light of the sector's ongoing focus on efficiency and electrification. This helps frame...
NYSE:MS
NYSE:MSCapital Markets

Morgan Stanley Backs Kalshi As Prediction Markets Enter Mainstream Finance

Morgan Stanley (NYSE:MS) invested in Kalshi's US$1b funding round. The deal centers on Kalshi, a regulated prediction market platform focused on event contracts. The investment highlights growing institutional interest in alternative risk trading infrastructure. Morgan Stanley, a large global financial services company, is adding exposure to regulated prediction markets through its backing of Kalshi. Event contracts sit at the intersection of trading, hedging, and data, and have been...
NasdaqGS:ARWR
NasdaqGS:ARWRBiotechs

Has Arrowhead Pharmaceuticals (ARWR) Run Too Far After Its 488% One Year Surge

If you are wondering whether Arrowhead Pharmaceuticals at around US$77.95 is still offering value or has already run too far, this breakdown is designed to help you frame that question clearly. The stock has returned 6.1% over the past week, 27.4% over the last 30 days, 15.0% year to date, and 488.3% over the past year, which naturally raises questions about how much of the story is already priced in. Recent coverage has focused on Arrowhead Pharmaceuticals' progress in RNA interference...
NYSE:WAT
NYSE:WATLife Sciences

Waters (WAT) Is Up 13.3% After Swing to Loss but Strong 2026 Revenue Guidance - What's Changed

Waters Corporation reported past first-quarter 2026 results with sales rising to US$1,267 million from US$662 million a year earlier, but swinging from net income of US$121 million to a net loss of US$72 million, with basic and diluted loss per share of US$0.87 from continuing operations. Alongside these results, Waters issued new guidance calling for very large second-quarter 2026 revenue of US$1.62 billion to US$1.63 billion and full-year 2026 revenue of US$6.41 billion to US$6.46 billion,...
NYSE:MAN
NYSE:MANProfessional Services

ManpowerGroup (MAN) Valuation Check After Recent Share Price Swings And Earnings Weakness

Context for ManpowerGroup after recent performance swings ManpowerGroup (MAN) has seen mixed share performance recently, with a 7.6% gain over the past month and a 16.9% decline over the past 3 months. This has put fresh attention on the stock’s current valuation. See our latest analysis for ManpowerGroup. Looking beyond the recent 7.6% 30 day share price return, ManpowerGroup’s 1 year total shareholder return of 23.3% and 5 year total shareholder return of 70.4% highlight how sentiment has...
NasdaqGS:AXTI
NasdaqGS:AXTISemiconductor

Is It Too Late To Consider AXT (AXTI) After Its Recent Share Price Surge

Some investors may be wondering whether AXT’s recent share price action still leaves room for value, or if the easy part of the move is already behind it. AXT last closed at US$108.42, with returns of 36.9% over 7 days, 138.5% over 30 days, very large gains year to date of 546.9% and roughly 82x over the past year. These moves can change how the market is viewing both its potential and its risks. Recent coverage has focused on AXT’s position in the semiconductor space and how investor...
NYSE:QGEN
NYSE:QGENLife Sciences

Assessing Qiagen (QGEN) Valuation After A Sharp Multi‑Month Share Price Pullback

Context on Qiagen’s recent share performance Qiagen (QGEN) has drawn attention after a run of weaker returns, with the stock down about 3% over the past week, 16% over the past month, and 34% over the past 3 months. See our latest analysis for Qiagen. Qiagen’s share price has lost momentum over 2024, with the recent 16.5% 1 month share price return and 34.2% 3 month share price return both negative, contributing to a 20.2% negative 1 year total shareholder return. If Qiagen’s recent pullback...
NYSE:CWK
NYSE:CWKReal Estate

Is Cushman & Wakefield (CWK) Pricing In Its Strong Multi Year Share Price Recovery?

Wondering whether Cushman & Wakefield's current share price reflects its true worth, or if the stock could be mispriced in the market right now? The stock recently closed at US$13.85, with a 1 year return of 35.3%, a 3 year return of 78.5%, a 5 year return of 25.6% decline, a 30 day return of 9.1% and a 7 day return of 1.4% decline. Recent coverage has focused on Cushman & Wakefield as part of the US real estate sector, with attention on how listed property related stocks are pricing in...
NYSE:CVI
NYSE:CVIOil and Gas

What CVR Energy (CVI)'s Q1 Losses, Higher Throughput and Dividend Decision Mean For Shareholders

In late April 2026, CVR Energy, Inc. reported first quarter 2026 results showing sales of US$1,980 million, a larger net loss of US$192 million, higher refining throughput, a US$0.10 per share cash dividend, and new production guidance for the second quarter. This combination of stronger volumes but wider losses, alongside the decision to pay a dividend, gives investors fresh insight into the company’s balance between growth, profitability, and cash returns. We’ll now examine how higher...
NasdaqGS:PI
NasdaqGS:PISemiconductor

Does Impinj’s Q2 Profitability Guidance After Flat Q1 Results Change The Bull Case For PI?

In April 2026, Impinj, Inc. reported first-quarter 2026 results showing essentially flat sales at US$74.25 million year over year, alongside a wider net loss of US$25.26 million and basic and diluted loss per share of US$0.83. At the same time, the company issued second-quarter 2026 guidance that, if achieved, would represent a shift from loss to positive GAAP net income and diluted earnings per share. We’ll now examine how Impinj’s move from a first-quarter loss to guided second-quarter...
NYSE:DEI
NYSE:DEIOffice REITs

Assessing Douglas Emmett (DEI) Valuation After FFO Beat And Record Leasing Update

Douglas Emmett (DEI) recently posted first quarter 2026 results that combined a small net loss with stronger funds from operations, record leasing volumes and expanding medical office exposure, giving investors fresh data on the stock. See our latest analysis for Douglas Emmett. The stock has reacted to the Q1 2026 earnings beat on funds from operations and record leasing activity with a 26.37% 1 month share price return. However, the 1 year total shareholder return of 11.62% decline and 5...
NYSE:ASB
NYSE:ASBBanks

How Associated Banc-Corp’s New Buyback, Dividends and Tech Oversight Will Impact ASB Investors

In late April 2026, Associated Banc-Corp’s board authorized a new common stock repurchase program of up to US$100 million, reaffirmed regular quarterly dividends on both common and preferred shares, and enacted board changes including the retirement of three directors and the creation of a Technology Committee overseeing data, IT, and cyber risk. This combination of refreshed governance, continued capital return through dividends and buybacks, and an added focus on technology and risk...
NasdaqGS:FFBC
NasdaqGS:FFBCBanks

First Financial Bancorp (FFBC) Valuation Check After Strong Q1 2026 Results And Recent Acquisitions

First Financial Bancorp (FFBC) is back in focus after reporting stronger Q1 2026 results, supported by higher net interest income, loan sale gains, and contributions from its recent Westfield and BankFinancial acquisitions. See our latest analysis for First Financial Bancorp. At a share price of $30.43, First Financial Bancorp has a 30.36% 1 year total shareholder return. The 3 year total shareholder return of 88.45% signals stronger longer term momentum than the recent 7% 1 month share price...
NYSE:DGX
NYSE:DGXHealthcare

Is It Time To Reassess Quest Diagnostics (DGX) After Recent Share Price Weakness?

If you are wondering whether Quest Diagnostics at around US$190.84 per share offers good value today, it helps to step back and look at the stock through a few different valuation lenses. The share price has seen mixed recent returns, with a 1.7% decline over 7 days and a 3.0% decline over 30 days, set against a 9.8% gain year to date and 10.4% over the past year, plus longer term returns of 54.8% over 3 years and 53.1% over 5 years. Recent coverage has focused on Quest Diagnostics as a US...
NYSE:TTI
NYSE:TTIEnergy Services

Assessing TETRA Technologies (TTI) Valuation After Recent Share Price Volatility

Why TETRA Technologies Stock Is On Investors’ Radar TETRA Technologies (TTI) has drawn interest after recent share price moves, with the stock showing mixed returns over the past week, month, and past 3 months. This has prompted investors to reassess its current valuation and business profile. See our latest analysis for TETRA Technologies. At a share price of US$9.77, TETRA Technologies has seen a 19.9% 1 month share price return but a 16.3% 3 month share price decline, while the 1 year...
NasdaqGS:CSWC
NasdaqGS:CSWCCapital Markets

Is Capital Southwest (CSWC) Pricing Too Optimistically After Its Strong 1 Year Share Price Run?

If you are wondering whether Capital Southwest stock still offers value at its current price, this article walks through the numbers so you can judge how the valuation stacks up for yourself. With the share price at US$23.99, recent returns of 6.3% over 30 days, 7.6% year to date and 35.5% over the past year put a clear spotlight on how investors are currently pricing the stock and what that might mean for future risk and reward. Those returns sit alongside a longer record, including 89.7%...
NYSE:ITT
NYSE:ITTMachinery

Assessing ITT (ITT) Valuation After Q1 2026 Earnings Beat And Acquisition Momentum

ITT’s latest earnings jolt investor attention ITT (ITT) drew fresh interest after its Q1 2026 results, where revenue and adjusted earnings topped consensus forecasts, helped by strong organic sales and the integration of SPX FLOW operations. See our latest analysis for ITT. Despite a 4.1% one day share price pullback after the results and a softer 7 day share price return, ITT’s 19.3% year to date share price return and very strong multi year total shareholder returns suggest that momentum...